Skip to main content

#160875

Anti-human IL-9 [MH9A4]

Cat. #160875

Anti-human IL-9 [MH9A4]

Cat. #: 160875

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Human IL-9 coupled to ovalbumin (This antibody was raised by immunising C57BI/6 mice with human IL-9 conjugated to ovalbumin)

Class: Monoclonal

Application: ELISA

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Cormont Francoise, Renauld Jean-Christophe, Uyttenhove Catherine, Van Snick Jacques

Institute: Ludwig Institute for Cancer Research

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-human IL-9 [MH9A4]
  • Alternate name: Anti-human Intereukin-9; IL-9
  • Research fields: Immunology
  • Clone: MH9A4
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Host: Mouse
  • Application: ELISA
  • Description: This antibody has been used in ELISA analysis to detect human IL-9 in allergen-stimulated peripheral blood mononuclear cell supernatants (Jenmalm et, 2001)

Target Details

  • Target: Human IL-9 coupled to ovalbumin (This antibody was raised by immunising C57BI/6 mice with human IL-9 conjugated to ovalbumin)

Applications

  • Application: ELISA

Handling

  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Jenmalm et al. 2001. Clin Exp Allergy. 31(10):1528-35. PMID: 11678852.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.